Dr. Mok Chi Chiu - Rheumatology
Specialist in Rheumatology
Highlights
- MCHK RegisteredVerified
- Specialist in RheumatologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Physicians · Medical degree 1990
- InsuranceBeing compiled|See details
About
Dr. Mok Chi Chiu is a registered Rheumatology specialist in Hong Kong.
Education
Specialist in Rheumatology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1990
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Mok Chi Chiu? Claim page and update insurance →
FAQ
Is Dr. Mok Chi Chiu any good?
Dr. Mok Chi Chiu is a registered Rheumatology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Mok Chi Chiu do?
Dr. Mok Chi Chiu practises in Rheumatology.
Are you Dr. Mok Chi Chiu? Claim this page to update and manage.
ClaimResearch and publications
135 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.Annals of the rheumatic diseases · 2026
- B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.Expert opinion on biological therapy · 2026
- Vaccination in systemic lupus erythematosus.Human vaccines & immunotherapeutics · 2026
- Herpes zoster vaccination and flares in rheumatic diseases.The Lancet. Rheumatology · 2026
- Lupus nephritis.Nature reviews. Disease primers · 2025
- The 2024 APLAR Consensus on the Management of Lupus Nephritis.International journal of rheumatic diseases · 2025
- Immunotargets and Therapy for Systemic Lupus Erythematosus.ImmunoTargets and therapy · 2025
- Glucocorticoid in systemic lupus erythematosus: the art beyond science.Expert review of clinical immunology · 2025
- The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DAS.Therapeutic advances in musculoskeletal disease · 2025
- Long COVID in patients with systemic lupus erythematosus: A case-control study.Lupus · 2025
- Distinct genetic risk loci between biopsy-proven renal and non-renal lupus: a 10-year longitudinal cohort.Rheumatology (Oxford, England) · 2025
- Anti-CD20 therapy in lupus nephritis: A revisit.Rheumatology and immunology research · 2025
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer